Huntleigh Technology
Article Abstract:
Huntleigh Technology has been affected by the high value of pound sterling, which has acted as a constraint on profit growth. The company should benefit from increased spending on the National Health Service (NHS) and the need of the NHS to replace a large number of beds. The company can source raw materials from countries using the euro, which offer lower prices. Huntleigh has reorganized its manufacturing, and is developing its telemedicine division. Sales of the company's portable diagnostic machines are rising by between 20% and 30% a year.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Ferraris
Article Abstract:
Ferraris produces respiratory devices so benefits from air pollution problems and is in a growing market. The company's acquisition of PDS is seen as a good move, thoogh integrating acquisitions can be problematic.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Breathing life into business
Article Abstract:
Feraris is a producer of medical equipment which is helped by a rise in asthma and a demand for products allowing self-administration of medicines. The company's medical components side accounts for over 80% of profits and revenues, with engineering accounting for the remainder. The engineering business focuses on the life sciences and scientific market, and is based in Germany. The group also holds a 5% stake in Bioprocessing, a biotechnology concern.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Reading the signs of movement in trust discounts. Extreme valuations. US shares: searching hard for the downside
- Abstracts: Lighting customers' fires. Smooth operators. Million dollar madness
- Abstracts: Searching for the right chemistry. Patent row kills merger
- Abstracts: Bring Budget day to your fingertips. Awaiting the Bank's verdict. Dear prudence...
- Abstracts: Techmark: key data on high tech stocks. Overload - broker bedlam hits the UK. The future is, almost, now